资产减值(商誉、无形资产及其他长期资产)

港股IPO招股书披露先例 · 222 家公司,235 项

资产减值事项涵盖收购产生的商誉、特许权及资本化开发成本等无形资产,以及厂房设备等长期资产的减值测试及关键假设。申请人通常在概要、风险因素、业务及财务资料章节披露账面值、现金产生单元分配、折现率、长期增长率等关键假设及敏感度分析,并说明无减值系缓冲空间充足,或减值源于行业下行、资产迭代等特定原因。

2026-09-28Prospectus
北京奕斯伟计算技术股份有限公司Beijing ESWIN Computing Technology Co., Ltd.01256.HK

商誉及无形资产大额减值致商誉清零

During the Track Record Period, we recognized impairment loss on intangible assets and goodwill of RMB72.1 million, RMB56.6 million, RMB90.9 million, nil and RMB85 thousand in 2023, 2024, 2025 and for the three months ended March 31, 2025 and 2026, respectively, primarily because certain historical acquisitions would not generate the benefits as originally expected after evaluation of the business performance.

Financial Information · 第 264 页

In particular, our goodwill decreased from RMB111.1 million as of December 31, 2023 to RMB54.5 million as of December 31, 2024 and further to nil as of December 31, 2025 and March 31, 2026 primarily attributable to impairment provisions made in accordance with valuation performed by independent third parties based on the fair value of the businesses acquired.

Financial Information · 第 276 页

Impairment review on the goodwill has been conducted by the management at each of the reporting year end.

Financial Information · 第 276 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-09-28Prospectus
北京奕斯伟计算技术股份有限公司Beijing ESWIN Computing Technology Co., Ltd.01256.HK

物业厂房及设备减值亏损

During the Track Record Period, we recognized impairment loss on property, plant and equipment of RMB3.6 million, RMB22.0 million, RMB35.1 million, RMB9.8 million and RMB0.7 million in 2023, 2024, 2025 and for the three months ended March 31, 2025 and 2026, respectively, primarily because a number of machines and equipment within certain business units had become obsolete and ceased to be operational.

Financial Information · 第 264 页

At each year end, we assessed the recoverable amounts of those assets were nil and as a result the carrying amount of the machines was written down to their recoverable amount.

Financial Information · 第 264 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-09-27Application Proof
上海寅家电子科技股份有限公司Voyager Intelligent Systems Limited

收购产生的商誉及客户关系无形资产

The carrying value of our goodwill were nil, RMB6.2 million, RMB6.2 million and RMB6.2 million as of December 31, 2023, 2024 and 2025 and June 30, 2026, respectively.

Financial Information · 第 229 页

Goodwill is stated at cost less accumulated impairment losses.

Financial Information · 第 229 页

The carrying value of our other intangible assets increased from RMB10.1 million as of December 31, 2023 to RMB177.8 million as of December 31, 2024, primarily due to an increase of RMB175.3 million in customer relationship, as a result of the Acquisition.

Financial Information · 第 229 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-09-21Prospectus
彤程新材料集团股份有限公司Red Avenue New Materials Group Co., Ltd.09607.HK

商誉4.37亿元经减值测试后无减值

Our goodwill remained constant at approximately RMB437.4 million as at the end of each financial year/period during the Track Record Period in accordance with the results of our impairment testing of goodwill, as detailed in the paragraphs below.

Financial Information · 第 236 页

As at 31 December 2023, 31 December 2024, 31 December 2025 and 30 June 2026, based on the value-in-use calculations applying the above key parameters, the recoverable amount of the semiconductor photoresist CGU exceeded its carrying amount by approximately RMB34.1 million, RMB64.3 million, RMB415.2 million and RMB308.0 million, respectively, and the recoverable amount of the display panel photoresist CGU exceeded its carrying amount by RMB378.7 million, RMB409.4 million, RMB522.8 million and RMB493.3 million, respectively.

Financial Information · 第 237 页

Based on the headroom computed as presented in the table above, our management believes that any reasonably possible change in any of the key parameters would not cause the respective carrying amount of each CGU to exceed its recoverable amount and thereby result in an impairment provision of goodwill.

Financial Information · 第 238 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-09-18Application Proof
浙江京新药业股份有限公司Zhejiang Jingxin Pharmaceutical Co., Ltd.

药品CGU商誉减值

The carrying value of our goodwill remained relatively stable at RMB348.5 million, RMB348.5 million and RMB335.6 million as of December 31, 2023, 2024 and 2025, respectively.

Financial Information · 第 226 页

The carrying amount of the Drugs CGU, which belongs to the Drugs segment, was impaired by RMB12,880,000 and RMB19,900,000 during the year ended December 31, 2025 and six months ended June 30, 2026, respectively.

Financial Information · 第 226 页

The impairment was attributable to the increasing competitive business landscape for Chinese finished medicines in Chinese Mainland.

Financial Information · 第 226 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-09-14Prospectus
纳真科技公司Ligent Technologies, Inc.09856.HK

电信光模块生产线因需求下降计提减值

As of December 31, 2024, 2025 and June 30, 2026, the carrying amount of certain production machinery was reduced to the recoverable amount of RMB1.1 million, RMB0.6 million and RMB0.3 million through recognition of impairment of RMB7.5 million, RMB4.2 million and RMB2.6 million, respectively, mainly because some of our telecom transceiver production lines became obsolete in light of declines in market demand.

Financial Information · 第 196 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-09-13PHIP
湖南军信环保股份有限公司Hunan Junxin Environmental Protection Co., Ltd.

收购仁和商誉1.46亿元及减值测试

Goodwill arising from the acquisition has been allocated to these CGUs based on their respective business types.

Financial Information · 第 240 页

The transaction also resulted in the recognition of goodwill amounting to RMB146 million.

Business · 第 161 页

As of December 31, 2024 and 2025, the headroom calculated based on the recoverable amounts deducting the carrying amount of the Renhe Environment Technology CGU was RMB391.8 million and RMB573.8 million.

Financial Information · 第 241 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-09-11Prospectus
星环信息科技(上海)股份有限公司Transwarp Technology (Shanghai) Co., Ltd.06727.HK

无形资产增至9,280万元并持续进行减值评估

Our intangible assets saw a significant increase from RMB21.9 million as of December 31, 2023, to RMB52.8 million as of December 31, 2024, and then increased to RMB88.4 million in 2025, and further increased to RMB92.8 million as of March 31, 2026, primarily due to the capitalization of expenses in relation to our research and development activities in the respective periods.

Financial Information · 第 237 页

We identified indicators of impairment for non-current assets including property and equipment, right-of-use assets and intangible assets including development costs as the continuing losses position as of December 31, 2023, 2024 and 2025 and March 31, 2026.

Financial Information · 第 238 页

Based on the results of impairment assessment, there are no impairment losses recognized during the Track Record Period.

Financial Information · 第 238 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-09-07PHIP
浙江涛涛车业股份有限公司Zhejiang Taotao Vehicles Co., Ltd.

收购产生商誉1.77亿元及无形资产

We recognized goodwill of RMB177.0 million as of December 31, 2025, representing the excess of the acquisition cost, including cash consideration and trade receivables, over the fair value of the identifiable net assets acquired.

Financial Information · 第 244 页

Based on the impairment assessment, the recoverable amount of the Champion Holdings CGU exceeded its carrying amount, including goodwill, by RMB46.1 million and RMB51.5 million as of December 31, 2025 and April 30, 2026, respectively.

Financial Information · 第 245 页

For the goodwill impairment test performed as of December 31, 2025, if the operating profit margin had been 8.70% lower, or the pre-tax discount rate had been 12.77% higher, or the annual revenue growth rate had been 0.50% lower, the carrying amount of the CGU would exceed its recoverable amount.

Financial Information · 第 245 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-09-03Application Proof

收购产生的商誉及客户关系无形资产

Our goodwill increased significantly from nil as of December 31, 2023 to RMB31.5 million as of December 31, 2024, further increased to RMB67.8 million as of December 31, 2025 and June 30, 2026, primarily due to business acquisitions completed during the year.

Financial Information · 第 183 页

Our intangible assets significantly increased from RMB6.4 million as of December 31, 2023 to RMB19.3 million as of December 31, 2024, primarily due to an increase in customer relationships, driven by the acquisition of XMSAIL and Shenzhen GoingGreen.

Financial Information · 第 183 页

Goodwill acquired through business combinations is allocated to six cash generating units (CGU) for impairment testing, including SZXM, ABITIO, SZ GoingGreen, Shuyou, AXIS and Newbest.

Financial Information · 第 183 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-09-03Application Proof
深圳信立泰药业股份有限公司SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.

PTH现金产生单位商誉于2023年全额减值

As of December 31, 2023, due to further decrease in revenue of this CGU in 2023, an additional impairment provision of RMB49.6 million was recognized.

Financial Information · 第 243 页

Prior to the Track Record Period, an impairment of goodwill of RMB26.6 million was recognized, due to the adjustment in the commercialization of PTH products.

Financial Information · 第 243 页

The recoverable amount of this CGU has been determined based on a value in use calculation using cash flow projections based on financial budgets covering a five-year period approved by our management.

Financial Information · 第 243 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-09-03Application Proof
深圳信立泰药业股份有限公司SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.

临床结果不佳致延后开发成本连年减值

With respect to deferred development costs, in 2024 and 2025, according to the impairment test, we recognized impairment loss of RMB137.1 million and RMB151.1 million, respectively, due to unsatisfactory clinical trial results.

Financial Information · 第 244 页

As of December 31, 2023, 2024, and 2025, and June 30, 2026, the headroom for deferred development costs in total was RMB673.5 million, RMB536.5 million, RMB824.3 million, and RMB1,217.8 million.

Financial Information · 第 244 页

In the opinion of our Directors, no reasonably possible changes in any of the key assumptions would cause the recoverable amounts of non-patent technologies and deferred development costs to be materially lower than the carrying amounts.

Financial Information · 第 244 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-08-31Prospectus
深圳市江波龙电子股份有限公司Shenzhen Longsys Electronics Co., Ltd.09976.HK

商誉约8至8.7亿元并每年减值测试

As of December 31, 2023, 2024, 2025 and April 30, 2026, our goodwill amounted to RMB868.7 million, RMB794.0 million, RMB820.2 million and RMB845.6 million, respectively.

Financial Information · 第 256 页

We determine whether goodwill is impaired at least on an annual basis. This requires an estimation of the value in use of the CGUs to which the goodwill is allocated.

Financial Information · 第 256 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-08-30Application Proof
浙江海亮股份有限公司ZHE JIANG HAI LIANG CO., LTD.

商誉减值测试及关键假设

Our intangible assets primarily consisted of (i) goodwill, and (ii) software.

Financial Information · 第 238 页

Impairment review on the goodwill of our Group have been conducted by the management as of December 31, 2023, 2024, 2025 and May 31, 2026, according to IAS 36 Impairment of assets.

Financial Information · 第 239 页

Based on the results of impairment test, for the CGUs that were not impaired during the years ended December 31, 2023, 2024 and 2025, and May 31, 2026, these recoverable amount of the CGUs is significantly above the carrying amount of our Group.

Financial Information · 第 241 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-08-28Application Proof
贝达药业股份有限公司Betta Pharmaceuticals Co., Ltd.

商誉4.14亿元并计提2,990万元减值

We recorded goodwill of RMB413.6 million, RMB413.6 million, RMB413.6 million and RMB383.7 million as of December 31, 2023, 2024 and 2025 and June 30, 2026, respectively, mainly in relation to our acquisition of Anew Pharmaceuticals.

Financial Information · 第 233 页

The decrease was mainly due to our impairment loss of RMB29.9 million as of June 30, 2026 in relation with the latest business and development progress of EYP-1901.

Financial Information · 第 233 页

For the six months ended June 30, 2026, the recoverable amount of the CGU is determined by our Directors with reference to the valuation report issued by an independent professional valuer based on fair value less cost of disposal, which is higher than its value-in-use.

Financial Information · 第 233 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-08-28Application Proof
贝达药业股份有限公司Betta Pharmaceuticals Co., Ltd.

无形资产约27亿元,开发成本减值测试

Our intangible assets remained relatively stable at RMB2,676.7 million as of December 31, 2025 and RMB2,721.4 million as of June 30, 2026.

Financial Information · 第 231 页

Development costs are tested for impairment annually by comparing their carrying amount with their recoverable amounts to which the intangible asset is related.

Financial Information · 第 232 页

Based on the result of assessment, there was no impairment loss on the development cost during the Track Record Period.

Financial Information · 第 232 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-08-28Prospectus
深圳麦科田生物医疗技术股份有限公司Medcaptain Medical Technology Co., Ltd.02041.HK

商誉约9.3亿元及无形资产的减值测试

Our goodwill amounted to RMB905.5 million, RMB905.5 million, RMB928.2 million and RMB927.8 million as of December 31, 2023, 2024 and 2025 and March 31, 2026, respectively.

Financial Information · 第 232 页

a decrease in the growth rate by 19.1%, 27.1%, 24.3% and 23.7% would cause the carrying amount of the cash-generating unit to exceed its recoverable amount as of December 31, 2023, 2024 and 2025 and March 31, 2026, respectively

Financial Information · 第 233 页

Based on the impairment assessments performed for each period during the Track Record Period, the recoverable amounts of the above-mentioned brands exceeded their respective carrying amounts, and no impairment losses were recognized.

Financial Information · 第 232 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-08-27Application Proof
迪哲(江苏)医药股份有限公司DIZAL PHARMACEUTICAL CO., LTD.

重大无形资产及减值测试假设

Our intangible assets primarily include intellectual property and software use rights.

Financial Information · 第 254 页

For the purpose of impairment testing, our management, with the assistance of independent professional valuer, identified our Group as a single CGU.

Financial Information · 第 243 页

Based on the results of the assessments, as the recoverable amount of the CGU is higher than the net carrying amount, no impairment loss on property, plant and equipment or intangible assets was recognized during the Track Record Period.

Financial Information · 第 243 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-08-25Application Proof
山东卓创资讯股份有限公司Sublime China Information Co., Ltd.

商誉5,110万元及数据资产等无形资产减值测试

We had goodwill of RMB51.1 million as at 31 December 2025 from the acquisition of Wuxi Chulei.

Financial Information · 第 221 页

The calculation uses cash flow projection based on financial forecast approved by management covering a 5-year period and pre-tax discount rate of 11.6%.

Financial Information · 第 221 页

Our intangible assets increased from RMB3.0 million as at 31 December 2023 to RMB35.3 million as at 31 December 2024, primarily due to the additions of data assets of RMB39.0 million because we began capitalising certain expenditure on commercial data resources as our data assets, which consists of the staff cost for generating data assets for generating our future revenue and it was complied with International Accounting Standards 38, Intangible Assets.

Financial Information · 第 220 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
2026-08-24Application Proof
浙江荣泰电工器材股份有限公司Zhejiang Rongtai Electric Material Co., Ltd.

收购Dizi Precision产生商誉人民币1.497亿元

We recorded goodwill of nil, nil, RMB149.7 million and RMB149.7 million in 2023, 2024, 2025 and June 30, 2026, respectively.

Financial Information · 第 222 页

Management performed an impairment assessment on the goodwill as of December 31, 2025 and June 30, 2026.

Financial Information · 第 222 页

Based on management’s assessment on the recoverable amount of the CGU, no impairment provision was considered necessary as of December 31, 2025 and June 30, 2026.

Financial Information · 第 223 页
公司的解释、律师意见及原文页码定位:在 Matters 中查看
1 / 12

Tell us